Resultados de procura - Nikhil Wagle
- Mostrando 1 - 20 Resultados de 62
- Go to Next Page
-
1
Clinical Analysis and Interpretation of Cancer Genome Data por Eliezer M. Van Allen, Nikhil Wagle, Mia Levy
Publicado 2013Revisão -
2
-
3
-
4
-
5
-
6
Rvb1p and Rvb2p Are Essential Components of a Chromatin Remodeling Complex That Regulates Transcription of over 5% of Yeast Genes por Zophonı́as O. Jónsson, Suman Kumar Dhar, Geeta J. Narlikar, Roy Auty, Nikhil Wagle, David Pellman, Richard E. Pratt, Robert E. Kingston, Anindya Dutta
Publicado 2001Artigo -
7
A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition por Steven R. Whittaker, Jean‐Philippe Theurillat, Eliezer M. Van Allen, Nikhil Wagle, Jessica Hsiao, Glenn S. Cowley, Dirk Schadendorf, David E. Root, Levi A. Garraway
Publicado 2013Artigo -
8
-
9
-
10
Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia por Andrew A. Lane, Oreofe O. Odejide, Nadja Kopp, Sunhee S. Kim, Akinori Yoda, Rachel Erlich, Nikhil Wagle, Gregory A. Abel, Scott J. Rodig, Joseph H. Antin, David M. Weinstock
Publicado 2013Carta -
11
Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma por Benjamin M. Ellingson, Timothy F. Cloughesy, Thiri Zaw, Albert Lai, Phioanh L. Nghiemphu, Robert J. Harris, Shadi Lalezari, Nikhil Wagle, Kourosh M. Naeini, Jose Carrillo, Linda M. Liau, Whitney B. Pope
Publicado 2012Artigo -
12
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling por Nikhil Wagle, W. Marston Linehan, Michael F. Berger, Matthew J. Davis, Allison M. Sawyer, Panisa Pochanard, Sarah M. Kehoe, Cory M. Johannessen, Laura E. MacConaill, William C. Hahn, Matthew Meyerson, Levi A. Garraway
Publicado 2011Artigo -
13
High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing por Nikhil Wagle, Michael F. Berger, Matthew J. Davis, Brendan Blumenstiel, Matthew DeFelice, Panisa Pochanard, Matthew D. Ducar, Paul Van Hummelen, Laura E. MacConaill, William C. Hahn, Matthew Meyerson, Stacey Gabriel, Levi A. Garraway
Publicado 2011Artigo -
14
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma por Jonathan E. Rosenberg, Richard Bambury, Eliezer M. Van Allen, Harry A. Drabkin, Primo N. Lara, Andrea Harzstark, Nikhil Wagle, Robert A. Figlin, Gregory W. Smith, Levi A. Garraway, Toni K. Choueiri, Fredrik Erlandsson, Damian A. Laber
Publicado 2013Artigo -
15
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies por Utthara Nayar, Ofir Cohen, Christian Kapstad, Michael S. Cuoco, Adrienne G. Waks, Seth A. Wander, Corrie Painter, Samuel S. Freeman, Nicole S. Persky, Lori Marini, Karla Helvie, Nelly Oliver, Orit Rozenblatt–Rosen, X. Cynthia, Aviv Regev, Eric P. Winer, Nancy U. Lin, Nikhil Wagle
Publicado 2018Artigo -
16
Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer por Sara M. Tolaney, Sally Tan, Hao Guo, William T. Barry, Eliezer M. Van Allen, Nikhil Wagle, Jane Brock, Katherine Larrabee, Cloud P. Paweletz, Elena Ivanova, Pasi A. Jänne, Beth Overmoyer, James R. Wright, Geoffrey I. Shapiro, Eric P. Winer, Ian E. Krop
Publicado 2015Artigo -
17
Oncogenic mutations in cervical cancer por Alexi A. Wright, Brooke E. Howitt, Andrea P. Myers, Suzanne E. Dahlberg, Emanuele Palescandolo, Paul Van Hummelen, Laura E. MacConaill, Melina Shoni, Nikhil Wagle, Robert T. Jones, Charles M. Quick, Anna Laury, Ingrid T. Katz, William C. Hahn, Ursula A. Matulonis, Michelle S. Hirsch
Publicado 2013Artigo -
18
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer por Yanan Kuang, Bilal A. Siddiqui, Jiani Hu, Matthew Pun, MacIntosh Cornwell, Gilles Buchwalter, Melissa E. Hughes, Nikhil Wagle, Paul Kirschmeier, Pasi A. Jänne, Cloud P. Paweletz, Nancy U. Lin, Ian E. Krop, William T. Barry, Eric P. Winer, Myles Brown, Rinath Jeselsohn
Publicado 2018Artigo -
19
Oncologists’ and cancer patients’ views on whole-exome sequencing and incidental findings: results from the CanSeq study por Stacy W. Gray, Elyse R. Park, Julie Najita, Yolanda Martins, Lara Traeger, Elizabeth F. Bair, Joshua J. Gagne, Judy E. Garber, Pasi A. Jänne, Neal I. Lindeman, Carol Lowenstein, Nelly Oliver, Lynette M. Sholl, Eliezer M. Van Allen, Nikhil Wagle, Sam Wood, Levi A. Garraway, Steven Joffe
Publicado 2016Artigo -
20
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial por Jorge Gómez Tejeda Zañudo, Romualdo Barroso‐Sousa, Esha Jain, Qingchun Jin, Tianyu Li, Jorge E. Buendia-Buendia, Alyssa Pereslete, Daniel L. Abravanel, Arlindo R. Ferreira, Eileen Wrabel, Karla Helvie, Melissa E. Hughes, Ann H. Partridge, Beth Overmoyer, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney, Nikhil Wagle
Publicado 2024Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Medicine
Genetics
Gene
Cancer
Internal medicine
Cancer research
Oncology
Breast cancer
Mutation
Metastatic breast cancer
Genome
Computational biology
Estrogen receptor
Pathology
Bioinformatics
Exome sequencing
Melanoma
Precision medicine
Signal transduction
Colorectal cancer
Gene expression
Kinase
MAPK/ERK pathway
Computer science
Exome
KRAS
Mutant
PI3K/AKT/mTOR pathway
Palbociclib